National Alliance on Mental Illness (NAMI) National Convention: June 28 – July 1
June 30, 2017Read moreThe 2017 NAMI National Convention – themed “Educate, Empower, Engage”– is recruiting top-notch researchers and clinicians to provide information and tools for advancing recovery from mental illness. At this conference, Dr. Magali Haas, CEO and President of Cohen Veterans Bioscience, will chair the workshop “Wearables and Mobile Health Platform for PTSD” on June 30th.
PTSD Awareness Month – June 2017
June 8, 2017Read moreJune is PTSD Awareness Month
Join us in observing PTSD Awareness Month. Each year, the U.S. Department of Veterans Affairs and organizations across the United States raise awareness about Post-Traumatic Stress Disorder.
7th Annual Traumatic Brain Injury Conference – May 24-25, 2017 in Washington, D.C.
May 24, 2017Read moreCohen Veterans Bioscience CEO & President Dr. Magali Haas is participating in a panel discussion at the 7th Annual Traumatic Brain Injury Conference, May 24-25, 2017 in Washington, D.C.
This conference brings together researchers and clinicians from industry, academia, the military and government to present ground-breaking research in a variety of areas related to traumatic brain injury.
State of the Science: Exploring Best Practices in Traumatic Stress Genomics – June 20, 2017 in Cambridge, MA
May 9, 2017Read moreCohen Veterans Bioscience and the Stanley Center for Psychiatric Genetics at the Broad Institute proudly sponsor a 1-day workshop to explore the state of the science in PTSD genetics and to share rationale and guidance for best practices in genomics research drawn from case studies of other areas of complex disease.
RAPID-Dx Consensus Conference – May 3-4, 2017 in Washington, D.C.
April 13, 2017Read moreThis Consensus Conference co-hosted by Cohen Veterans Bioscience and the National Institute of Alcohol Abuse and Alcoholism, will convene clinical, research, regulatory, drug & device development and statistical experts to discuss the advancement of biomarker qualification & diagnostic development and device qualification for trauma-related brain disorders and co-morbid conditions using a Case Study approach.
Events
